Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US7368469 | KING PHARMS LLC | Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events |
Aug, 2020
(3 years ago) |
Drugs and Companies using RAMIPRIL ingredient
Market Authorisation Date: 28 January, 1991
Treatment: Method of reducing risk of myocardial infarction, stroke and death
Dosage: CAPSULE;ORAL
Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US6066339 | KING PHARMS LLC | Oral morphine multiparticulate formulation |
Nov, 2017
(6 years ago) |
Drugs and Companies using MORPHINE SULFATE ingredient
Market Authorisation Date: 20 March, 2002
Treatment: NA
Dosage: CAPSULE, EXTENDED RELEASE;ORAL